News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Lawrence Boise: Looking for motivated postdocs to study factors that control mitochondrial priming and cell survival in multiple myeloma
Photo from Lawrence Boise/LinkedIn
Jan 8, 2024, 15:21

Lawrence Boise: Looking for motivated postdocs to study factors that control mitochondrial priming and cell survival in multiple myeloma

Quoting Lawrence Boise, R. Randall Rollins Chair in Oncology at Emory University School of Medicine, on LinkedIn:

”I’m hiring! Looking for motivated postdocs to study factors that control mitochondrial priming and cell survival in multiple myeloma. Come join the highly collaborative Winship Multiple Myeloma Team. Apply here.”

Source: Lawrence Boise/LinkedIn

cancer career opportunity cell survival Lawrence Boise mitochondrial priming multiple myeloma OncoDaily Oncology postdocs Winship Multiple Myeloma Team
Special Coverage
Insight
Mar 31, 2025, 05:03
Jarushka Naidoo: My ELCC 2025 Top 3 - MARIPOSA, KRYSTAL7 and Deescalation trials
Blog
Mar 31, 2025, 04:59
Michael Sapienza: Federal funding for cancer and other disease research has been cut by more than $1 billion
Blog
Mar 31, 2025, 04:45
Amil Družić: Excited to be part of the upcoming Young Cancer Professionals Roundtable
Blog
Mar 31, 2025, 03:27
Inside Cancer Careers Podcast Concluding – Thank You to our guests and listeners for two incredible years: Train at NCI
Blog
Mar 31, 2025, 02:59
Ariana Znaor: Consultation period for International Classification of Diseases for Oncology, 4th Edition is extended
Blog
Mar 31, 2025, 02:16
Peter Pisters: Delighted to serve as keynote speaker at Opportunity Austin's quarterly meeting
Blog
Mar 30, 2025, 23:21
Sachin H. Jain: How has "expert bias" mislead you in your work?
Blog
Mar 30, 2025, 22:48
HESI THRIVE 2025 Seed Grant Program - Funding Opportunity for Innovative Cancer Research
Insight
Mar 30, 2025, 21:29
Bishoy Morris Faltas: AI model that predicts response to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer
Blog
Mar 30, 2025, 20:28
Rob Winn: Leadership in healthcare is not just about strategy - it’s about people
Blog
Mar 30, 2025, 19:23
Transform the Future of Cancer Research by Leaving a Legacy This Free Wills Month - ICR
Blog
Mar 30, 2025, 19:05
New Council Recommendation on Vaccine-Preventable Cancers - European Cancer Organisation